A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|174|6|991-993

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.174, Iss.6, 2016-09, pp. : 991-993

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Factors Associated with Recovery of Renal Function in Patients with Multiple Myeloma Who Were Treated with Hemodialysis

By  

Nephron Clin Pract, Vol. 117, Iss. 1, 2010-08 ,pp. : c28-c32

Karger

Access to resources Recommend Favorite

The addition of dexamethasone to bortezomib for patients with relapsed multiple myeloma improves outcome but ongoing maintenance therapy has minimal benefit

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 5, 2015-05 ,pp. : E86-E91

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outcome of patients with multiple myeloma and hypotension during high‐dose chemotherapy

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 6, 2015-06 ,pp. : E125-E127

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiangiogenic Therapy in Multiple Myeloma

By  

Acta Haematologica, Vol. 106, Iss. 4, 2002-01 ,pp. : 208-213

Karger

Access to resources Recommend Favorite

Recombinant Human Erythropoietin Is Associated with Increased Overall Survival in Patients with Multiple Myeloma

By  

Acta Haematologica, Vol. 117, Iss. 3, 2006-12 ,pp. : 162-167

Karger

Access to resources Recommend Favorite